Emergent Biosolutions EBS Canada — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Emergent Biosolutions’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's canada — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's canada — total revenues?
- Emergent Biosolutions (EBS) reported canada — total revenues of $18.75M in Q4 2025.
- How has Emergent Biosolutions's canada — total revenues changed year-over-year?
- Emergent Biosolutions's canada — total revenues decreased by 46.6% year-over-year, from $35.1M to $18.75M.
- What is the long-term trend for Emergent Biosolutions's canada — total revenues?
- Over 4 years (2021 to 2025), Emergent Biosolutions's canada — total revenues has grown at a 3.0% compound annual growth rate (CAGR), from $66.7M to $75M.
- What does canada — total revenues mean?
- This metric represents the total gross income generated from the sale of goods and services within the Canadian geographic market. It reflects the company's ability to capture market share and monetize its public health product portfolio in this specific region. Tracking this figure helps investors assess the regional growth trajectory and the impact of local commercial strategies on overall corporate performance.